Your institution may have access to this item. Find your institution then sign in to continue.
Title
News in brief.
Abstract
The article offers news on scientific research. The British Human Fertilisation & Embryology Authority has not decided whether to accept two applications for work involving hybrid embryos. Sweden-based stem cell company Cellartis has signed a deal with ITI Life Sciences and the University of Glasgow in Scotland to develop human stem cells for pharmaceutical research.